plerixafor has been researched along with Paraproteinemias in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belizaire, R; Chen, YB; Makar, RS; Spitzer, TR; Sykes, DB | 1 |
| Bains, T; Bubalo, J; Chen, AI; Fowler, C; Knight, R; Maziarz, RT; Murray, S; Shoop, K; Slater, S | 1 |
2 other study(ies) available for plerixafor and Paraproteinemias
| Article | Year |
|---|---|
Difficulties in hematopoietic progenitor cell collection from a patient with TEMPI syndrome and severe iatrogenic iron deficiency.
Topics: Benzylamines; Cyclams; Cytapheresis; Erythrocytes, Abnormal; Erythropoietin; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Heterocyclic Compounds; Humans; Kidney Diseases; Leukocyte Count; Male; Middle Aged; Paraproteinemias; Polycythemia; Syndrome | 2015 |
Clinical experience with a simple algorithm for plerixafor utilization in autologous stem cell mobilization.
Topics: Adult; Aged; Algorithms; Benzylamines; Cyclams; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Lymphoma; Male; Middle Aged; Paraproteinemias; Transplantation, Autologous; Treatment Outcome | 2012 |